New bipolar disorder research highlights a wearable lithium sensor, how mood stabilizers affect thinking, and fathers’ ...
Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM ...
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases.It is currently ...
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies ...
The science community has pushed back at the latest claims that acetaminophen (aka paracetamol) is a key factor in the ...
The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that ...
As a person firmly ensconced in middle age — 57 percent of the way through life, to be precise, if government actuarial tables hold — I have begun to notice certain things not working quite as well as ...
Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.